Matriptase protects against experimental colitis and promotes intestinal barrier recovery
about
Protease inhibition as new therapeutic strategy for GI diseasesClaudins in intestines: Distribution and functional significance in health and diseasesDiscovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase InhibitorsInhibition of Matriptase Activity Results in Decreased Intestinal Epithelial Monolayer Integrity In VitroMatriptase zymogen supports epithelial development, homeostasis and regenerationDivergent Inhibitor Susceptibility among Airway Lumen-Accessible Tryptic ProteasesReinforced Epithelial Barrier Integrity via Matriptase Induction with Sphingosine-1-Phosphate Did Not Result in Disturbances in Physiological Redox Status.Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.Type II transmembrane serine proteases as potential targets for cancer therapy.Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis.The Transmembrane Serine Protease HAT-like 4 Is Important for Epidermal Barrier Function to Prevent Body Fluid Loss.Pathophysiological roles of proteases in gastrointestinal disease.Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function.The serine protease-mediated increase in intestinal epithelial barrier function is dependent on occludin and requires an intact tight junction.Regulation of Trek1 expression in nasal mucosa with allergic rhinitis by specific immunotherapy.Regulation of intestinal permeability: The role of proteasesDesign and synthesis of potent, selective inhibitors of matriptase.A Fluorescent-Labeled Phosphono Bisbenzguanidine As an Activity-Based Probe for Matriptase.Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis.Altered Prostasin (CAP1/Prss8) Expression Favors Inflammation and Tissue Remodeling in DSS-induced Colitis.Changing the selectivity profile - from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors.Panax notoginseng Promotes Repair of Colonic Microvascular Injury in Sprague-Dawley Rats with Experimental Colitis.Intestinal regulation of suppression of tumorigenicity 14 (ST14) and serine peptidase inhibitor, Kunitz type -1 (SPINT1) by transcription factor CDX2
P2860
Q26747722-5D146282-BCB4-43F0-A565-0EB85C78C572Q27000548-EEADE4FF-EBE4-4D7E-8B7B-A4EB178FD20EQ27684175-D388F0C9-B10C-4F91-AE97-0A81C39D9EA8Q28550435-58F77653-ED8C-4716-A7B3-80AB98F53FC3Q33749952-EABFF7C8-AFEA-4A40-91B4-D8392075B58EQ35814743-EAD2F16F-4CDC-4C77-8FBD-A15919D33579Q36448467-AC65E92C-DDEB-4154-B72F-E8D68A7D2F4BQ36567735-7DA1E2BB-4866-4DE3-8BFB-1E4F6AC6902DQ36760282-52FAC482-2308-49F3-BECD-B6BB30F5678FQ37168351-A836D47E-7285-4CB3-92F5-B5263903CC5FQ37610695-9E1B79E8-B9E5-4E5B-9214-F728E5C577D6Q37719392-7BCAFA68-962B-458F-AC8A-D604B62295CCQ38678675-F0912ACA-E279-4E94-956B-BC46784857B6Q38696638-2BA7AE20-2117-4417-AE68-96A0529E306BQ38753779-FD236E6F-1F2E-443F-B1E9-F0577C6C996CQ38926592-53EF645F-3B3C-4E11-840F-6CCAD1D3D8FCQ39239228-23F8D2F4-0031-4616-968E-EDE4AADFC869Q39734758-33A265B0-727C-4B3F-BBEC-E0EE5408D399Q50754826-AF914DA5-B088-4572-9547-483C6E5816D2Q51009956-5E788DDC-1E21-4F4E-A0FC-81CB4383E07FQ51379981-0D7841D0-F708-4386-ABBB-C1F0955AF46EQ53099256-9BF97826-C1C2-4BFC-AA10-1EF838264B6EQ54969801-D0022956-957D-403D-B70F-D0B340682354Q58797861-089CD819-09AA-406B-A55D-27CA431EA600
P2860
Matriptase protects against experimental colitis and promotes intestinal barrier recovery
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Matriptase protects against experimental colitis and promotes intestinal barrier recovery
@ast
Matriptase protects against experimental colitis and promotes intestinal barrier recovery
@en
type
label
Matriptase protects against experimental colitis and promotes intestinal barrier recovery
@ast
Matriptase protects against experimental colitis and promotes intestinal barrier recovery
@en
prefLabel
Matriptase protects against experimental colitis and promotes intestinal barrier recovery
@ast
Matriptase protects against experimental colitis and promotes intestinal barrier recovery
@en
P2093
P2860
P50
P356
P1476
Matriptase protects against experimental colitis and promotes intestinal barrier recovery
@en
P2093
Antoine Désilets
Marguerite S Buzza
Richard Leduc
Sarah Netzel-Arnett
Toni M Antalis
P2860
P304
P356
10.1002/IBD.21930
P577
2011-11-13T00:00:00Z